Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Is history of depression a contraindication to treatment with tetrabenazine?

Kenney C, Hunter C, Mejia N, Jankovic J.

Clin Neuropharmacol. 2006 Sep-Oct;29(5):259-64.

PMID:
16960470
2.

Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.

Chen JJ, Ondo WG, Dashtipour K, Swope DM.

Clin Ther. 2012 Jul;34(7):1487-504. doi: 10.1016/j.clinthera.2012.06.010. Epub 2012 Jun 28. Review.

PMID:
22749259
3.

Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.

Jankovic J, Clarence-Smith K.

Expert Rev Neurother. 2011 Nov;11(11):1509-23. doi: 10.1586/ern.11.149. Review.

PMID:
22014129
4.

Tetrabenazine.

Fasano A, Bentivoglio AR.

Expert Opin Pharmacother. 2009 Dec;10(17):2883-96. doi: 10.1517/14656560903386292. Review.

PMID:
19929707
5.

Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.

Setter SM, Neumiller JJ, Dobbins EK, Wood L, Clark J, DuVall CA, Santiago A.

Consult Pharm. 2009 Jul;24(7):524-37. Review.

PMID:
19689181
6.

Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.

Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF.

Laryngoscope. 2007 Jan;117(1):3-15. Review.

PMID:
17202923
7.

Tetrabenazine in the treatment of hyperkinetic movement disorders.

Kenney C, Jankovic J.

Expert Rev Neurother. 2006 Jan;6(1):7-17. Review.

PMID:
16466307

Supplemental Content

Support Center